Cargando…
Effectiveness and safety of secukinumab in ankylosing spondylitis: real-life data from Midlands Ankylosing Spondylitis Collaboration (MASC)
Autores principales: | Ajibade, Adeola, Pandian, Haridha, Jain, Nibha, Gupta, Latika, Laxminarayan, Ramasharan, Moorthy, Arumugam, Amarasena, Roshan, Cox, Natasha, Sapkota, Hem, Kakade, Girish, Elamanchi, Srinivasa, Prabu, Athiveeraramapandian, Al-Samaraaie, Elaf, Barkham, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023240/ https://www.ncbi.nlm.nih.gov/pubmed/36938322 http://dx.doi.org/10.1093/rap/rkad029 |
Ejemplares similares
-
Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016) -
Secukinumab: A Review in Ankylosing Spondylitis
por: Blair, Hannah A.
Publicado: (2019) -
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
por: Blair, Hannah A.
Publicado: (2019) -
Role of secukinumab in ankylosing spondylitis with tubercular uveitis
por: Mahendradas, Padmamalini, et al.
Publicado: (2020) -
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
por: Emery, Paul, et al.
Publicado: (2018)